Spectral CT provides multi-parametric imaging data and is useful in predicting Ki-67 expression in ovarian cancer, delivering comprehensive and reliable imaging evidence for the formulation of therapeutic treatment options. This evidence concerns the gene MKI67 and ovarian carcinoma.